Antimicrobial properties of 4-Aryl-3-(2-methyl-furan-3-yl) δ2-1,2,4-triazoline-5-thiones

Phosphorus, Sulfur and Silicon and the Related Elements

Volumn 184, Issue 12, 2009, Pages 3149-3159

  Siwek, Agata ^a   Wujec, Monika ^a   Stefańska, Joanna ^b   Paneth, Piotr ^c  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

2 1,2,4 triazoline 5 thione; Antimicrobial activity; QSAR

Indexed keywords

EID: 74949094438     PISSN: 10426507     EISSN: 15635325     Source Type: Journal    
DOI: 10.1080/10426500802705297     Document Type: Article

References (34)

1. (a) N. S. Günay, G. Çapan, N. Ulusoy, N. Ergenç, G. Ötük, and D. Kaya, Il Farmaco, 54, 826 (1999);
2. (b) A. A. Ikizler, C. B. Johansson, O. Bekircan, and C. Çelik, Acta Polon. Pharm.-Drug Research, 56, 283 (1999);
3. (c) Ş. Demirayak, K. Benkli, and K. Güven, Eur. J. Med. Chem., 35, 1073 (2000);
4. (d) X-P. Hui, L-M. Zhang, Z-Y Zhang, Q. Wang, and F. Wang, J. Chin. Chem. Soc., 47, 535 (2000);
5. (e) N. N. Gulerman, H. N. Dogan, S. Rollas, C. Johansson, and C. Celik, Farmaco, 56, 935 (2001);
6. (f) B. S. Holla, B. K. Sarojini, B. S. Rao, P. M. Akberali, N. S. Kumari, and V. Shetty, Farmaco, 56, 565 (2001);
7. (g) U. Kosikowska, A. Siwek, and M. Dobosz, Acta Polon. Pharm.-Drug Research, 51, 460 (2004);
8. (h) B. Tozkoparan, E. Kupeli, E. Yesilada, S. Isik, M. Ozalp, and M. Ertan, Arzneimittelforschung, 55, 533 (2005);
9. (i) O. A. Al-Deeb, M. A. Al-Omar, N. R. El-Brollosy, E. E. Habib, T. M. Ibrahim, and A. A. El-Emam, Arzneim. Forsch., 56, 40 (2006);
10. (j) B. Shivarama Holla, B. Sooryanarayana Rao, B. K. Sarojini, P. M. Akberali, and N. Suchetha Kumari, Eur. J. Med. Chem., 41, 657 (2006);
11. (k) A. Gürsoy, Ö. Ates, N. Karali, N. Cesur, and M. Kiraz, Eur. J Med Chem , 31, 643 (1996);
12. (l) Ch.-H. Chu, X.-P., Hui, Y. Zhang, Z.-Y. Zhang, Z.-Ch. Li, and R.-A. Liao, J. Chin. Chem. Soc., 48, 121 (2001);
13. (m) M. Wujec, M. Pitucha, M. Dobosz, U. Kosikowska, and A. Malm, Acta Pharm., 54, 251 (2004);
14. (n) L. Savini, L. Chiasserini, C. Pellerano, W. Filippelli, and G. Falcone, Farmaco, 56, 939 (2001);
15. (o) B. Tozkoparam, E. Yesilada, and M. Ertan, Bioorg. Med. Chem., 15, 1808 (2007);
16. (p) M. V. Kulkarni, V. D. Patil, V. N. Biradar, and S. Nanjappa, Arch. Pharmacal. Res., 34, 435 (1981);
17. (q) E. Palaska, G. Şahin, P. Kelicen, N. T. Durlu, and G. Altinok, Il Farmaco, 57, 101 (2002);
18. (r) L. Labanauskas, V. Kalcas, E. Udrenaite, P. Gaidelis, A. Brukštus, and V. Daukšas, Pharmazie, 56, 617 (2001);
19. (s) L. Labanauskas, E. Udrenaite, P. Gaidelis, and A. Brukštus, Il Farmaco, 59, 255 (2004);
20. (t) B. Modzelewska-Banachiewicz, J. Banachiewicz, A. Chodkowska, E. Jagiello-Wójtowicz, and L. Mazur, Eur. J. Med. Chem., 39, 873 (2004);
21. (u) X-Y. Sun, Y-Z. Jin, F-N. Li, G. Li, K-Y. Chai, and Z-S. Quan, Archives of Pharmacological Research, 29, 1080 (2006);
22. (v) W. R. Sherman, J. Org. Chem., 26, 88 (1961);
23. (w) A. R. Jalilian, S. Sattari, M. Bineshmarvasti, A. Shafiee, and M. Daneshtalab, Arch. Pharm. Med. Chem., 333, 347 (2000).
24. (a) E. B. Åkerblom and D. E. S. Campbell, Eur. J. Med. Chem., 16, 312 (1973);
25. (b) H. E. Paul and M. F. Paul, Exp. Chemother., 2, 322 (1964);
26. (c) K. Hayes, J. Med. Chem., 7, 819 (1964);
27. (d) F. C. Meotti, D. Silva, A. R. S. dos Santos, G. Zeni, J. B. T. Rocha, and C. W. Nogueira, Environ. Toxicol. Pharmacol., 37, 37 (2003).
28. A. Siwek, M. Wujec, E. Jagiełło-Wójtowicz, A. Chodkowska, A. Kleinrok, P. Paneth, and M. Dobosz, Cent. Eur. J. Chem., 6, 47 (2008).
29. A. Siwek, M. Wujec, I. Wawrzycka-Gorczyca, M. Dobosz, and P. Paneth, Heteroatom Chem., 19, 337 (2008).
30. (a) Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disc Susceptibility Tests; Approved Standard M2-A9. Clinical and Laboratory Standards Institute, Wayne, PA, USA, 2006;
31. (b) Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA, USA, 2006.
32. G. B. Rocha, R. O. Freire, A. M. Simas, and J. J. P. Stewart, J. Comput. Chem., 27, 1101 (2006).
33. HyperChem 8.0.3, HyperCube Inc., Gainsville, FL, USA, 2007.
34. http://www.molinspiration.com/cgi-bin/properties.